205 related articles for article (PubMed ID: 25929302)
1. The new occlutech duct occluder: immediate results, procedural challenges, and short-term follow-up.
Kudumula V; Taliotis D; Duke C
J Invasive Cardiol; 2015 May; 27(5):250-7. PubMed ID: 25929302
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
3. Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?
Godart F; Houeijeh A; Domanski O; Guillaume MP; Brard M; Lucron H
Int J Cardiol; 2018 Jun; 261():54-57. PubMed ID: 29551254
[TBL] [Abstract][Full Text] [Related]
4. Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech® Duct Occluder: A Multicenter Study.
Dedeoglu R; Bilici M; Demir F; Demir F; Acar OÇ; Hallioglu O; Pac A; Kiziltas A; Karabel D; Kula S; Cimen D; Baspinar O; Atik SU; Saltik IL
J Interv Cardiol; 2016 Jun; 29(3):325-31. PubMed ID: 27090770
[TBL] [Abstract][Full Text] [Related]
5. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
6. Closure of the patent ductus arteriosus with the Amplatzer Duct Occluder II: a clinical experience.
Karagöz T; Akin A; Ertuğrul I; Aykan HH; Alehan D; Ozer S; Ozkutlu S
Acta Cardiol; 2012 Dec; 67(6):675-80. PubMed ID: 23393938
[TBL] [Abstract][Full Text] [Related]
7. Does a Change in Device Design Alter Device Size Selection? A Comparison of Conventional and Occlutech Duct Occluder Designs.
Subramanian A; Paraswanath BA; Govind Auradkar ; Mahimarangaiah J
Heart Lung Circ; 2022 Dec; 31(12):1677-1684. PubMed ID: 36089464
[TBL] [Abstract][Full Text] [Related]
8. The Amplatzer Duct Occluder II Additional Sizes device for transcatheter PDA closure: initial experience.
Bruckheimer E; Godfrey M; Dagan T; Levinzon M; Amir G; Birk E
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1097-101. PubMed ID: 24532416
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children.
Kang SL; Morgan G; Forsey J; Tometzki A; Martin R
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1102-8. PubMed ID: 24403100
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
11. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
[TBL] [Abstract][Full Text] [Related]
12. [Transcatheter closure of patent ductus arteriosus using the Amplatzer duct occluder in children: initial and one-year results].
Parra-Bravo JR; Cruz-Ramírez A; Toxqui-Terán A; Juan-Martínez E; Chávez-Fernández AA; Lazo-Cárdenas C; Beirana-Palencia L; Estrada-Flores J
Arch Cardiol Mex; 2009; 79(2):114-20. PubMed ID: 19722381
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results.
Peirone A; Diaz J; Contreras A; Banille E; Cabrera M; Spillmann A; Bueno N; Juaneda E
J Invasive Cardiol; 2011 Dec; 23(12):513-6. PubMed ID: 22147399
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion.
Bhole V; Miller P; Mehta C; Stumper O; Reinhardt Z; De Giovanni JV
Catheter Cardiovasc Interv; 2009 Nov; 74(5):762-9. PubMed ID: 19522000
[TBL] [Abstract][Full Text] [Related]
15. Cardi-O-Fix duct occluder versus Amplatzer duct occluder for closure of patent ductus arteriosus.
Celebi A; Demir IH; Saritaş T; Dedeoğlu R; Yucel IK; Demir F; Erdem A
Catheter Cardiovasc Interv; 2013 Nov; 82(6):961-7. PubMed ID: 23592558
[TBL] [Abstract][Full Text] [Related]
16. The new Occlutech® PDA occluder: Initial human experience.
Abdelbasit MA; Alwi M; Kandavello G; Che Mood M; Samion H; Hijazi ZM
Catheter Cardiovasc Interv; 2015 Jul; 86(1):94-9. PubMed ID: 25675888
[TBL] [Abstract][Full Text] [Related]
17. Unconventional uses of septal occluder devices: Our experience reviewed.
Awasthy N; Tomar M; Radhakrishnan S; Shrivastava S
Indian Heart J; 2015; 67(2):128-35. PubMed ID: 26071291
[TBL] [Abstract][Full Text] [Related]
18. Patent ductus arteriosus closure using the new Amplatzer Duct Occluder. Preliminary results and review of the literature.
Zanchetta M; Dimopoulos K; Rigatelli G; Pedon L; Zennaro M; Pieri D; Rubino A; Bartorelli AL; Maiolino P; Onorato E
Minerva Cardioangiol; 2001 Dec; 49(6):369-76. PubMed ID: 11733731
[TBL] [Abstract][Full Text] [Related]
19. Early clinical experience with a modified Amplatzer ductal occluder for transcatheter arterial duct occlusion in infants and small children.
Kenny D; Morgan GJ; Bentham JR; Wilson N; Martin R; Tometzki A; Oslizlok P; Walsh KP
Catheter Cardiovasc Interv; 2013 Oct; 82(4):534-40. PubMed ID: 22718329
[TBL] [Abstract][Full Text] [Related]
20. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study.
Sungur M; Karakurt C; Ozbarlas N; Baspinar O
Catheter Cardiovasc Interv; 2013 Aug; 82(2):245-52. PubMed ID: 23460349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
